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PSEN1 for mutations in 48 individuals
with HS and identified three variants in
coding regions and splice sites of
NCSTN. To our knowledge these var-
iants are previously unreported. We
present evidence consistent with patho-
genicity of two of these alleles, adding
to the spectrum of described mutations
in this gene. Neither individual in
whom mutations were identified re-
ported a family history of HS demon-
strating the importance of NCSTN in
sporadic disease. These data confirm
that germline mutations of g-secretase
are confined to a minority of subjects
who develop HS and suggest that
additional and as yet unknown genes
predispose to the development of this
distressing disorder.
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TO THE EDITOR
The mammalian epidermis is maintained
by epithelial stem cells (SCs) capable of
self-renewal and differentiation (Fuchs,
2009). Although the transcription factor
p63 is critical for the proliferative
potential of epithelial SCs (Senoo et al.,
2007), the molecular events underlying
their transition to more differentiated
progenitors remain largely unknown.
Technical challenges in distinguishing
SCs from transit-amplifying (TA) cells,
early progeny of SCs (Watt, 2001),
complicate such analyses and impede
development of new strategies to im-
prove SC quality for therapeutic trans-
plantation and SC-directed gene therapy.
A current model dictates that SCs in
the interfollicular epidermis are located
in the basal layer, whereas TA cells are
found in both the basal and suprabasal
layers (Watt, 2001; Fuchs, 2008). As
epidermal SCs express relatively high
levels of p63 (p63hi) in culture (Pellegrini
et al., 2001; Senoo et al., 2007), we first
investigated whether p63hi cells were
restricted to the epidermal basal layer.
To identify the basal layer, we used
integrin b4 (Radoja et al., 2006). Un-
expectedly, we found p63hi cells in both
basal and suprabasal layers in adult
human epidermis (Figure 1a and b),
suggesting that high p63 expression is
not restricted to SCs. Because the
decrease in p63 expression accom-
panying epidermal cell differentiation
appears linked to phosphorylation and
consequent targeting for proteasome-
mediated degradation (Westfall et al.,
2005), we next asked whether initiation
of SC differentiation is accompanied by
an increase in p63 phosphorylation.
Abbreviations: CK14, cytokeratin-14; HPEK, human primary epidermal keratinocyte; SC, stem cell;
TA, transit amplifying
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Toward this end, we first assessed
total p63 and pp63 levels in individual
adult human epidermal cells by quanti-
tative immunofluorescence. The speci-
ficity of anti-pp63 antibodies was
verified by immunohistochemistry and
western blot analysis (Supplementary
Figure S1 online). Our data show that
pp63 levels were variable within cells
with similar p63 levels, including those
with high p63 expression (Figure 1a,
insets and lower panels). Notably, p63hi
cells with extremely low p63 phosphor-
ylation were found exclusively in the
basal layer, whereas those with in-
creased p63 phosphorylation were ob-
served in both the basal and suprabasal
layers (Figure 1a and c). These data
suggest that epidermal SCs are included
in the p63hipp63lo basal layer popula-
tion and that p63hi cells with increased
levels of p63 phosphorylation represent
more differentiated epidermal progeni-
tor cells.
To investigate how pp63 levels
change in relation to total p63 expres-
sion during epidermal cell differentia-
tion, we analyzed Ca2þ -induced
differentiation of human primary epi-
dermal keratinocytes (HPEKs). Consis-
tent with an earlier report (Westfall
et al., 2003), stimulation of HPEKs with
high Ca2þ led to a rapid decrease in
total p63 expression and an associated
increase in the pp63/p63 ratio (Figure
1d and e). These changes were accom-
panied by a rapid decrease in integrin
b1, a marker associated with epidermal
SC function (Jones and Watt, 1993), and
a significant increase in total and cross-
linked involucrin, a marker for terminal
differentiation (Banks-Schlegel and
Green, 1981).
Notably, however, we found that
stimulation of HPEKs with lower Ca2þ
led to a gradual increase in p63
phosphorylation, with unchanged total
p63 expression (Figure 1e), suggesting
that phosphorylation of p63 precedes
differentiation-dependent, proteasome-
mediated degradation of p63. In
support, integrin b1 expression was
sustained in HPEKs cultured in lower
Ca2þ and increased involucrin expres-
sion was restricted to lower-molecular-
weight forms (Figure 1d). Although the
latter effect appears as sensitive as p63
phosphorylation in vitro, basal and first
suprabasal cells in the epidermis do
not express detectable levels of these
terminal differentiation markers (Banks-
Schlegel and Green, 1981). Thus, we
conclude that increased p63 phosphor-
ylation is a useful marker that can be
used to detect the initiation of epider-
mal cell differentiation both in vitro and
in vivo before a significant decrease in
p63 expression is observed.
Next, we sought to determine
whether changes in pp63 levels reflect
the proliferative potential of epidermal
SCs in clonogenic cultures designed for
generation of therapeutic skin grafts
(Green, 2008). In these systems, epider-
mal cells form three types of clones:
holoclones, meroclones, and para-
clones, in decreasing order of prolifera-
tive potential and p63 expression and
increasing order of differentiation
(Barrandon and Green, 1987; Pellegrini
et al., 2001; Senoo et al., 2007).
Holoclones consist primarily of SCs,
are homogeneous for high p63 expres-
sion, and are morphologically immature
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Figure 1. Expression of p63 and pp63 in human epidermis and cultured keratinocytes.
(a) Immunofluorescence staining of normal human epidermis for p63, pp63, and integrin b4. Insets
and lower panels are enlarged views of representative suprabasal (S) and basal (B) cells, respectively.
Arrowheads and arrows indicate representative p63hi cells with relatively low and high p63
phosphorylation, respectively; DNA, nuclear counterstaining. Bars¼ 20mm. (b) Comparison of the p63
levels normalized by nuclear counterstaining between the basal (integrin b4þ , n¼ 58) and suprabasal
(integrin b4, n¼192) cells from a single image by box-and-whisker plots. Shown are representative data
from three independent experiments with similar results. (c) Histogram of the pp63/p63 ratio among p63hi
cells (top 50% in b). *, Not detectable. (d) Western blot analysis of Ca2þ -induced differentiation of
human primary epidermal keratinocytes. (e) Quantification of d for the changes in p63 levels and the
pp63/p63 ratio with time.
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(Supplementary Figure S2 online). Long-
term culture of holoclones generates
meroclone-producing cells, which re-
present more differentiated epidermal
progenitors. As such, these cultures are
ideal for studying early stages of SC
differentiation into TA cells.
Notably, we found that although
total p63 expression in holoclones was
uniformly high cells located within the
center showed increased pp63 levels
compared with those near the periphery
(Figure 2a–d). Staining with an anti-
cytokeratin-14 (CK14) antibody, a
marker for immature epidermal cells
(Bragulla and Homberger, 2009), re-
vealed that both peripheral and central
cells in holoclones expressed similarly
high levels of CK14 that differed sig-
nificantly from those in meroclone-
forming cells (Figure 2c and Supple-
mentary Figure S2 online). These data
indicate that single holoclone-forming
SCs produce p63hi cells with variable
levels of pp63 and that cells with
relatively low and high levels of pp63
can be distinguished by their relative
location within holoclones.
To determine whether p63hi cells
with increased pp63 levels had reduced
proliferative potential, we performed
clonogenic analysis of isolated cells
from the center and periphery of
holoclones. Isolated cells were cultured
at clonal density, and equal percen-
tages of cells were serially passaged at
2-week intervals. Our data show that
although peripheral cells with relatively
low levels of pp63 continuously formed
holoclones at high efficiency through
multiple passages the proliferative po-
tential of central cells with higher
levels of pp63 declined rapidly (Figure
2e and f). These data clearly indicate
that phosphorylation of p63 inversely
correlates with the proliferative poten-
tial of epidermal cells and that pp63
levels distinguish self-renewing SCs
from TA cells with more limited pro-
liferative potential.
Our current work demonstrates that
high p63 expression alone is not
sufficient to identify epidermal SCs
and that increased p63 phosphorylation
serves as a biomarker that delineates
exit from the SC state into more
differentiated progenitors. Thus, our
studies highlight the significance of
posttranslational modification of SC
self-renewal factors in adult SCs. In-
vestigation of the signals responsible for
p63 phosphorylation will likely provide
essential insight into the signaling path-
ways that regulate self-renewal and
differentiation of epidermal SCs.
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Figure 2. pp63 levels and the proliferative potential of epidermal stem cells. (a) Immunofluorescence
staining of holoclones (Holo) for p63 and pp63. Dotted lines indicate the clone border. Bars¼50 mm.
(b) Left, expression of p63 and pp63 in the peripheral and central cells isolated from Holo. Right,
comparison of the pp63/p63 ratios between the peripheral (n¼ 83) and central (n¼ 74) cells by box-and-
whisker plots. DNA, nuclear counterstaining. Bar¼ 20mm; **Po0.01. (c) Western blot analysis of p63,
pp63, and CK14 levels in the peripheral (p) and central (c) cells from Holo and whole (w) meroclone
(Mero)-forming cells. (d) Quantification of the pp63/p63 ratio from the data shown in c. **Po0.01.
(e) Representative data for the proliferative potential of cells isolated from the periphery and the center
of Holo at passage 3. (f) Comparison of Holo-forming efficiency between peripheral and central cells at
different passages (n¼3). *Po0.05; **Po0.01.
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Dermatology Life Quality Index (DLQI): A Paradigm Shift
to Patient-Centered Outcomes
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TO THE EDITOR
We thank Dr Nijsten (2012) for his
positive comments concerning the ubi-
quity and impressive track record of the
Dermatology Life Quality Index (DLQI),
and for agreeing that it is reliable, valid,
and easy to use. In the Editorial,
attention is drawn to theoretical limita-
tions of the measure and at the same
time Skindex is promoted.
It is implied that the questions of the
DLQI were ‘‘yselected by the re-
searchers based on existing tools, with-
out input from patients’’. In fact, the
questions were derived entirely from
the experience of 120 adult patients
with a variety of skin diseases (Finlay
and Khan, 1994), as acknowledged
previously (Nijsten et al., 2006). This
aspect of the DLQI has been a major
strength of this instrument in that the
questions have a high face validity with
patients, reflecting the reality of the
patient experience in living with skin
disease. In contrast to the conclusions
reached by Twiss et al. (2012), in-depth
interviews with patients with psoriasis
revealed that patients considered that
all of the important ways in which
their lives were affected by psoriasis
were covered by the DLQI questions
(Safikhani et al., 2011). Scrutiny of the
DLQI in its use in many hundreds of
research studies has unfolded new
properties or reconfirmed its original
concepts (Basra et al., 2008).
Nijsten states that the Item Response
Theory (IRT) methodology is considered
the ‘‘gold standard’’ in the develop-
ment of Health-Related Quality of Life
(HRQoL) instruments, and we agree
that it is important to use the highest
quality psychometric techniques such
as the IRT. However, this does not
mean that the Classical Test Theory
(CTT) is wrong; it is still being used for
the development and validation of new
HRQoL instruments (Evers et al., 2008),
and the person and item statistics
derived from these two measurement
models are comparable (Xitao, 1998;
Lin, 2008).
CTT has the advantage that data
are not fitted to a predetermined
mathematical model, and thus assump-
tions do not need to be met before
developing this framework, and a dis-
advantage of Rasch analysis is the need
for larger sample sizes. Skindex-29 was
created using the CTT and does not fit
the Rasch model (though Skindex-17
does); thus, it is not possible to say from
a methodological viewpoint whether
it is worse or better than the DLQI.
Although Nijsten quotes evidence
against the unidimensionality of the
DLQI (Nijsten et al., 2006), there are
other reports supporting its unidimen-
sional nature and hence the use of a
summary score (Mork et al., 2002;
Lennox and Leahy, 2004; Mazzotti
et al., 2005; Takahashi et al., 2006;
He et al., 2011).
Nijsten has suggested a ‘‘genera-
tion’’ classification of HRQoL tools,
but not every quality-of-life (QoL) tool
fits neatly into this labeling scheme.
Although by being the first dermatol-
ogy-specific tool the DLQI is by defini-
tion ‘‘first generation’’, its questions
were entirely based on the views of
Abbreviations: CTT, Classical Test Theory; DLQI, Dermatology Life Quality Index; HRQoL, Health-
Related Quality of Life; IRT, Item Response Theory; QoL, quality of life
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